| scholarly article | Q13442814 |
| P50 | author | Felix Rey | Q20434957 |
| Carlos Kikuti | Q90702012 | ||
| Patrick England | Q28322928 | ||
| Annette Martin | Q30503790 | ||
| P2093 | author name string | Aure Saulnier | |
| Bruno Baron | |||
| Bruno Robert | |||
| Daniel X Johansson | |||
| Isabelle Petitpas | |||
| Jacques d'Alayer | |||
| Laurence Damier-Piolle | |||
| Rajiv G Tawar | |||
| Thomas Krey | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus | Q24307963 | ||
| The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus | Q24652906 | ||
| Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes | Q27469599 | ||
| Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein | Q27469721 | ||
| Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins | Q27469844 | ||
| Folding of hepatitis C virus E1 glycoprotein in a cell-free system. | Q27469881 | ||
| Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum | Q27472959 | ||
| A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry | Q27477463 | ||
| Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding | Q27477468 | ||
| Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes | Q27477610 | ||
| Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin | Q27480329 | ||
| Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization | Q27481012 | ||
| Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus | Q27481024 | ||
| Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding | Q27481026 | ||
| Structural basis of viral invasion: lessons from paramyxovirus F | Q27481675 | ||
| Oligomerization-dependent folding of the membrane fusion protein of Semliki Forest virus | Q27485868 | ||
| Viral membrane fusion | Q27486639 | ||
| Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees | Q27489101 | ||
| Human occludin is a hepatitis C virus entry factor required for infection of mouse cells | Q27490169 | ||
| Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain | Q27490335 | ||
| The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH | Q27631190 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry | Q28131832 | ||
| A structural perspective of the flavivirus life cycle | Q29616269 | ||
| Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein | Q29618169 | ||
| Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus | Q29619744 | ||
| Virus membrane-fusion proteins: more than one way to make a hairpin | Q29620769 | ||
| Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins | Q29620952 | ||
| Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. I. Assignments and model compounds | Q30419238 | ||
| Identification and application of the concepts important for accurate and reliable protein secondary structure prediction | Q34408246 | ||
| Class III viral membrane fusion proteins | Q34789408 | ||
| Challenges and successes in developing new therapies for hepatitis C. | Q36233823 | ||
| Structural insights into SARS coronavirus proteins | Q36303186 | ||
| Class II virus membrane fusion proteins | Q36346783 | ||
| Flavivirus membrane fusion | Q36590420 | ||
| Virus membrane fusion | Q36744226 | ||
| Assembly of a functional HCV glycoprotein heterodimer. | Q36815840 | ||
| Hepatitis C virus entry | Q36946317 | ||
| Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity | Q39955792 | ||
| Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry | Q40557371 | ||
| Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins | Q40562324 | ||
| Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus | Q42677821 | ||
| Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus | Q42982262 | ||
| A model for the hepatitis C virus envelope glycoprotein E2. | Q42999033 | ||
| Coiled coils in both intracellular vesicle and viral membrane fusion | Q44268531 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | e1000762 | |
| P577 | publication date | 2010-02-19 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule | |
| P478 | volume | 6 |
| Q39788993 | 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses |
| Q40288437 | A Biologically-validated HCV E1E2 Heterodimer Structural Model |
| Q28475468 | A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry |
| Q36433948 | A Single Maturation Cleavage Site in Adenovirus Impacts Cell Entry and Capsid Assembly |
| Q38729824 | A novel membrane fusion protein family in Flaviviridae? |
| Q39428400 | A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization |
| Q35872590 | A systematic analysis of a broadly neutralizing antibody AR3C epitopes on Hepatitis C virus E2 envelope glycoprotein and their cross-reactivity |
| Q37805839 | Adaptive Immunity to the Hepatitis C Virus |
| Q42250599 | Alanine scanning mutagenesis of hepatitis C virus E2 cysteine residues: Insights into E2 biogenesis and antigenicity |
| Q27684354 | An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission |
| Q28659586 | Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution |
| Q35942829 | Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding |
| Q24623612 | Bats are a major natural reservoir for hepaciviruses and pegiviruses |
| Q37611819 | CD81 and hepatitis C virus (HCV) infection. |
| Q30374314 | Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design |
| Q24633191 | Characterization of a canine homolog of hepatitis C virus |
| Q36598453 | Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication |
| Q36559862 | Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry |
| Q34120689 | Characterization of the envelope glycoproteins associated with infectious hepatitis C virus |
| Q37905942 | Class II enveloped viruses |
| Q38083515 | Clinical impact of hepatitis B and C virus envelope glycoproteins |
| Q39520011 | Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure-function relationships |
| Q55003572 | Computational Modeling of Hepatitis C Virus Envelope Glycoprotein Structure and Recognition. |
| Q38985716 | Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus |
| Q33691856 | Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2. |
| Q36506935 | Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein |
| Q42269411 | Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry. |
| Q27677276 | Crystal structure of glycoprotein E2 from bovine viral diarrhea virus |
| Q47137438 | Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens |
| Q36281158 | Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction |
| Q45324948 | Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1. |
| Q43046695 | Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2. |
| Q36559948 | Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein. |
| Q38097291 | Early events in foamy virus-host interaction and intracellular trafficking |
| Q38046287 | Entry and replication of recombinant hepatitis C viruses in cell culture |
| Q58787270 | Evolutionary diversification of the HAP2 membrane insertion motifs to drive gamete fusion across eukaryotes |
| Q42153341 | Expression, purification and crystallization of the ectodomain of the envelope glycoprotein E2 from Bovine viral diarrhoea virus |
| Q27683712 | Functional and evolutionary insight from the crystal structure of rubella virus protein E1 |
| Q37662365 | GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling. |
| Q33988533 | Generation of a cell culture-adapted hepatitis C virus with longer half life at physiological temperature |
| Q26801759 | Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design |
| Q34806845 | Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks. |
| Q27666147 | Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography |
| Q38244787 | HCV E2 core structures and mAbs: something is still missing. |
| Q56910948 | HCV envelope glycoproteins in evirion assembly and entry |
| Q38384140 | HCV glycoprotein structures: what to expect from the unexpected |
| Q34455275 | Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses |
| Q27680704 | Hepatitis C Virus E2 Envelope Glycoprotein Core Structure |
| Q36086218 | Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion |
| Q35213305 | Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry |
| Q56911131 | Hepatitis C virus entry into the hepatocyte |
| Q42988476 | Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization. |
| Q39444247 | Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature |
| Q35182834 | Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion |
| Q34792436 | Hepatitis C virus life cycle and lipid metabolism |
| Q38410753 | Hepatitis C virus vaccines in the era of new direct-acting antivirals |
| Q27676139 | High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells |
| Q37682499 | How hepatitis C virus invades hepatocytes: the mystery of viral entry |
| Q34228030 | Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus |
| Q28482261 | Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate |
| Q27666330 | Identification of New Functional Regions in Hepatitis C Virus Envelope Glycoprotein E2 |
| Q34262175 | Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors |
| Q39545671 | Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entry |
| Q38334024 | Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees. |
| Q37144953 | Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex. |
| Q37859393 | Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2. |
| Q38195180 | Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion |
| Q42271360 | Infectivity of hepatitis C virus correlates with the amount of envelope protein E2: development of a new aptamer-based assay system suitable for measuring the infectious titer of HCV. |
| Q34059233 | Isolation and characterization of the DNA and protein binding activities of adenovirus core protein V. |
| Q35261158 | Last stop before exit - hepatitis C assembly and release as antiviral drug targets |
| Q52593865 | Lectin microarray and mass spectrometric analysis of hepatitis C proteins reveals N-linked glycosylation. |
| Q38728810 | Lettuce-produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination. |
| Q35274913 | Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations |
| Q42282554 | Mass spectrometric analysis of hepatitis C viral envelope protein E2 reveals extended microheterogeneity of mucin-type O-linked glycosylation |
| Q28476811 | Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol |
| Q38120526 | Multiantibody strategies for HIV. |
| Q37629584 | Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies |
| Q37512845 | Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG. |
| Q36404194 | Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape? |
| Q36395837 | Neutralizing antibodies and pathogenesis of hepatitis C virus infection |
| Q27027484 | Neutralizing antibody response to hepatitis C virus |
| Q38335402 | Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step |
| Q35914270 | New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A. |
| Q43041914 | New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles |
| Q40286085 | Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56+ natural killer cell responses in chronic HCV-infected patients. |
| Q38208100 | Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity |
| Q37408926 | Post-translational modifications of hepatitis C viral proteins and their biological significance |
| Q47238536 | Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis |
| Q28085146 | Proteomic approaches to analyzing hepatitis C virus biology |
| Q26766136 | Recent advances in understanding hepatitis C |
| Q42003229 | Recombinant pestivirus E2 glycoproteins prevent viral attachment to permissive and non permissive cells with different efficiency |
| Q38187796 | Relating structure to evolution in class II viral membrane fusion proteins |
| Q34295953 | Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions |
| Q39406155 | Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function |
| Q35677448 | Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission |
| Q33646044 | Single strain isolation method for cell culture-adapted hepatitis C virus by end-point dilution and infection |
| Q38324768 | Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus |
| Q30760929 | Stability, orientation and position preference of the stem region (residues 689-703) in Hepatitis C Virus (HCV) envelope glycoprotein E2: a molecular dynamics study. |
| Q27678252 | Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape |
| Q57064243 | Structural Proteins of HCV and Biological Functions |
| Q38128299 | Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies |
| Q34983278 | Structural and functional characterization of the single-chain Fv fragment from a unique HCV E1E2-specific monoclonal antibody |
| Q34064882 | Structural basis for broad neutralization of hepatitis C virus quasispecies |
| Q27679280 | Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 |
| Q24598370 | Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81 |
| Q41619358 | Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies. |
| Q41232999 | Structural insights into adiponectin receptors suggest ceramidase activity. |
| Q56911058 | Structural knowledge of HCV envelope protein region recognized by broadly neutralizing antibodies |
| Q39033934 | Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets |
| Q37902736 | Structure and working of viral fusion machinery |
| Q27681839 | Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 |
| Q40189989 | Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2. |
| Q45326105 | Structure-function dissection of the Pseudorabies virus glycoprotein B fusion loops |
| Q38615654 | Targeting HCV entry for development of therapeutics |
| Q37824811 | Targeting cell entry of enveloped viruses as an antiviral strategy. |
| Q37675742 | The Ancient Gamete Fusogen HAP2 Is a Eukaryotic Class II Fusion Protein |
| Q54216802 | The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific. |
| Q39234549 | The Arg719 residue at the C-terminal end of the stem region in hepatitis C virus JFH-1 E2 glycoprotein promotes viral infection |
| Q34481429 | The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development. |
| Q56944979 | The Involvement of Tight Junction Protein Claudin-1 in Hepatitis C Virus Entry |
| Q33924522 | The Strange, Expanding World of Animal Hepaciviruses |
| Q46255773 | The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human αVβ3 Integrin via Steric Hindrance |
| Q34000089 | The hepatitis C virus E1 glycoprotein undergoes productive folding but accelerated degradation when expressed as an individual subunit in CHO cells |
| Q27023390 | The hepatitis C virus glycan shield and evasion of the humoral immune response |
| Q27693297 | The impact of hepatitis C virus entry on viral tropism |
| Q37498626 | The ins and outs of hepatitis C virus entry and assembly |
| Q33360674 | The missing pieces of the HCV entry puzzle |
| Q99726781 | The prefusion structure of herpes simplex virus glycoprotein B |
| Q41672624 | The unexpected structures of hepatitis C virus envelope proteins |
| Q27673453 | Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody |
| Q37699395 | Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. |
| Q30364309 | Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. |
| Q38613576 | Unraveling hepatitis C virus structure |
| Q36380849 | Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration. |
| Q34096483 | Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation |
| Q38086754 | Virion assembly and release |
| Q38104471 | Virus-neutralizing antibodies to hepatitis C virus |
| Q33815695 | Within-host dynamics of the hepatitis C virus quasispecies population in HIV-1/HCV coinfected patients |
Search more.